<?xml version="1.0" encoding="UTF-8"?>
<p id="p0170">The localization of ACE2 receptors in the endocrine pancreas raises the question if COVID-19 infection is a risk factor for development of dysglycemia. A previous report showed that patients infected with SARS coronavirus - and not treated with glucocorticoids - showed transient hyperglycemia due to acute damage of beta cells induced by the virus, occurring within 3 days and 2 weeks after hospitalization 
 <xref rid="b0260" ref-type="bibr">[52]</xref>.
</p>
